These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20877345)

  • 1. Active adenoviral vascular penetration by targeted formation of heterocellular endothelial-epithelial syncytia.
    Chen HH; Cawood R; El-Sherbini Y; Purdie L; Bazan-Peregrino M; Seymour LW; Carlisle RC
    Mol Ther; 2011 Jan; 19(1):67-75. PubMed ID: 20877345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
    Allen C; McDonald C; Giannini C; Peng KW; Rosales G; Russell SJ; Galanis E
    J Gene Med; 2004 Nov; 6(11):1216-27. PubMed ID: 15459967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GALV expression enhances the therapeutic efficacy of an oncolytic adenovirus by inducing cell fusion and enhancing virus distribution.
    Guedan S; Grases D; Rojas JJ; Gros A; Vilardell F; Vile R; Mercade E; Cascallo M; Alemany R
    Gene Ther; 2012 Nov; 19(11):1048-57. PubMed ID: 22113313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syncytia formation affects the yield and cytotoxicity of an adenovirus expressing a fusogenic glycoprotein at a late stage of replication.
    Guedan S; Gros A; Cascallo M; Vile R; Mercade E; Alemany R
    Gene Ther; 2008 Sep; 15(17):1240-5. PubMed ID: 18509378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusogenic membrane glycoproteins induce syncytia formation and death in vitro and in vivo: a potential therapy agent for lung cancer.
    Lin EH; Salon C; Brambilla E; Lavillette D; Szecsi J; Cosset FL; Coll JL
    Cancer Gene Ther; 2010 Apr; 17(4):256-65. PubMed ID: 19893593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas.
    Galanis E; Bateman A; Johnson K; Diaz RM; James CD; Vile R; Russell SJ
    Hum Gene Ther; 2001 May; 12(7):811-21. PubMed ID: 11339897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of a fusogenic glycoprotein, prodrug activation, and oncolytic herpes simplex virus for enhanced local tumor control.
    Simpson GR; Han Z; Liu B; Wang Y; Campbell G; Coffin RS
    Cancer Res; 2006 May; 66(9):4835-42. PubMed ID: 16651439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a replication-competent retroviral vector for expression of the VSV-G envelope glycoprotein for cancer gene therapy.
    Jin SY; Jung YT
    Arch Virol; 2020 May; 165(5):1089-1097. PubMed ID: 32146506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral fusogenic membrane glycoprotein expression causes syncytia formation with bioenergetic cell death: implications for gene therapy.
    Higuchi H; Bronk SF; Bateman A; Harrington K; Vile RG; Gores GJ
    Cancer Res; 2000 Nov; 60(22):6396-402. PubMed ID: 11103804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the cytotoxicity of fusogenic membrane glycoproteins in gliomas through protease-substrate interaction.
    Johnson KJ; Peng KW; Allen C; Russell SJ; Galanis E
    Gene Ther; 2003 May; 10(9):725-32. PubMed ID: 12704411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy of lung adenocarcinoma using herpes virus expressing a fusogenic membrane glycoprotein.
    Zhu B; Yang JR; Jiang YQ; Chen SF; Fu XP
    Cell Biochem Biophys; 2014 Jul; 69(3):583-7. PubMed ID: 24510538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display.
    Fielding AK; Chapel-Fernandes S; Chadwick MP; Bullough FJ; Cosset FL; Russell SJ
    Hum Gene Ther; 2000 Apr; 11(6):817-26. PubMed ID: 10779159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The myeloid-binding peptide adenoviral vector enables multi-organ vascular endothelial gene targeting.
    Lu ZH; Kaliberov S; Zhang J; Muz B; Azab AK; Sohn RE; Kaliberova L; Du Y; Curiel DT; Arbeit JM
    Lab Invest; 2014 Aug; 94(8):881-92. PubMed ID: 24955893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect.
    Fu X; Tao L; Jin A; Vile R; Brenner MK; Zhang X
    Mol Ther; 2003 Jun; 7(6):748-54. PubMed ID: 12788648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
    Zhang J; Frolov I; Russell SJ
    J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat-directed tumor cell fusion.
    Brade AM; Szmitko P; Ngo D; Liu FF; Klamut HJ
    Hum Gene Ther; 2003 Mar; 14(5):447-61. PubMed ID: 12691610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer into marrow repopulating cells: comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons.
    Kiem HP; Heyward S; Winkler A; Potter J; Allen JM; Miller AD; Andrews RG
    Blood; 1997 Dec; 90(11):4638-45. PubMed ID: 9373277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for acute myeloid leukemia using Sindbis vectors expressing a fusogenic membrane glycoprotein.
    Tan L; Xu B; Liu R; Liu H; Tan H; Huang W
    Cancer Biol Ther; 2010 Mar; 9(5):350-7. PubMed ID: 20061812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly efficient tumor transduction and antitumor efficacy in experimental human malignant mesothelioma using replicating gibbon ape leukemia virus.
    Kubo S; Takagi-Kimura M; Logg CR; Kasahara N
    Cancer Gene Ther; 2013 Dec; 20(12):671-7. PubMed ID: 24201868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor effects of gene therapy with GALV membrane fusion glycoprotein in lung adenocarcinoma.
    Zhu B; Yang JR; Fu XP; Jiang YQ
    Cell Biochem Biophys; 2014 Jul; 69(3):577-82. PubMed ID: 24519667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.